SCHEMBL15413122

SCHEMBL15413122

COc1cc(OC)c(Cl)c(Cc2cc3cnc(Nc4c(C)cccc4N)nc3[nH]c2=O)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 14/20 0.46
▸ FGFR1 P11362 11/20 0.44
▸ FGFR2 P21802 2/20 0.44
▸ FGFR3 P22607 2/20 0.44
▸ CYP1A2 P05177 1/20 0.41
▸ CSF1R P07333 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SIK2 Q9H0K1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23289853 0.85 FGFR4 (0.54) FGFR4FGFR1FGFR2FGFR3
SCHEMBL21386642 0.77 FGFR4 (0.68) FGFR4FGFR1FGFR2FGFR3CYP3A4
SCHEMBL18134014 0.77 FGFR4 (0.51) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL20094066 0.73 FGFR4 (0.49) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL15413124 0.73 FGFR1 (0.45) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL15413472 0.72 FGFR4 (0.70) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL15434031 0.72 FGFR1 (0.67) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL15434045 0.72 FGFR1 (0.67) FGFR4FGFR1FGFR2FGFR3CYP1A2
SCHEMBL15413093 0.72 FGFR1 (0.72) FGFR4FGFR1
SCHEMBL15434003 0.71 FGFR4 (0.65) FGFR4FGFR1FGFR2FGFR3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872491-A2 INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR Blueprint Medicines Corporation (US) 2015-05-20 — — EP disclosed
WO-2014011900-A2 INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR BLUEPRINT MEDICINES (US) 2014-01-16 — — WO disclosed
Send feedback